What You Should Know: - Thomas H. Lee Partners, a premier private equity firm investing in growth companies, announced today that it has entered into an agreement to acquire a majority interest in Intelligent Medical Objects, a healthcare data enablement company and market leader in clinical terminology solutions in a $1.5B + deal. - Founded in 1994, IMO manages more than 5 million clinical terms and maps to all major coding systems. Its suite of software products, which is used by over
Read More
Healthcare Private Equity | PE | M&A| News, Analysis, Insights
Day 3 HIMSS Roundup: Glooko Acquires DIABNEXT, GE Healthcare/AliveCor Integration
Venture Capital, Private Equity, Mergers & Acquisitions (M&A) Activity Glooko Acquires DIABNEXT® to Expand Diabetes Offerings in France Glooko, a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, today announced the acquisition of DIABNEXT, a Paris-based company whose digital health platform helps people with diabetes better manage their conditions and connects to their healthcare providers, so they can
Read More
How Support Automation Enhances Clinical Trial Management
The life of a clinical study relies on data from documentation, meetings, emails and calls; all of which can be overwhelming for patients, clinical trial teams and associates. Although mundane, documenting, executing and collecting data is crucial to move a trial from phase to phase. Clinical trial teams face a multitude of competing priorities, from evaluating hundreds of potential patients to maintaining compliance and recording patient progress. No aspect or step can be neglected for a
Read More
GTCR Acquires Majority Stake in Experity to Drive On-Demand Care
What You Should Know: - Experity, the national leader in on-demand care solutions, today announced a strategic growth investment from GTCR, a private equity firm with significant experience in healthcare technology and services. Existing investor Warburg Pincus will retain a minority interest in the company - The strategic growth investment from GTCR, along with the combined capability of two world-class investors (including Warburg Pincus) will provide industry-leading innovation and
Read More
PE Firm WCAS Launches $300M Value-Based Care Portfolio Company, Valtruis
What You Should Know: Welsh, Carson, Anderson & Stowe (“WCAS”), a leading private equity firm focused exclusively on the healthcare and technology industries, announced that it is launching Valtruis, a unique portfolio company that will invest in and partner with value-based care driven healthcare companies. WCAS is committing an initial $300M to this platform. Founded on a commitment to accelerate meaningful change, Valtruis brings the functional expertise, access to capital and an
Read More
PE Firm Warburg Pincus Makes Minority Investment in GHX, Thoma Bravo Exits
What You Should Know: - GHX, a healthcare supply chain leader announced it has entered into a definitive agreement to receive a strategic investment from private equity firm Warburg Pincus. As part of this transaction, minority investor Thoma Bravo has exited its investment. Existing investor Temasek, an investment company headquartered in Singapore, will remain the majority equity holder. - GHX has employees in the United States, Canada and Europe and is known for operating the largest
Read More
PE Firm Frazier Healthcare Partners Closes $1.4B Growth Buyout Fund
What You Should Know: - Frazier Healthcare Partners, a Seattle-based healthcare private equity firm announced the close of its tenth global buyouts fund and 13th fund across buyouts and life sciences. Investment focus will continue to be middle market provider-based businesses, with virtual health as a major component. The oversubscribed $1.4 billion fund, FHGB X, is significantly larger than FHGB IX, which closed at $780M in 2018. - Frazier, 30 years strong this year,
Read More
PE Firm Thoma Bravo Acquires Clinical Trial Financial Platform Greenphire – Health M&A
What You Should Know: - Thoma Bravo, a private equity investment firm focused on the software and technology-enabled services sector announced that it has reached an agreement to acquire Greenphire, a financial lifecycle management software for clinical trials, from The Riverside Company. Financial details were not disclosed for the pending transaction. - The acquisition, which is subject to customary regulatory approvals, is expected to close in the second quarter of this year. -
Read More
Q1 2021 Health IT/Digital Health PC/VE, M&A, IPOs/ SPACs Activity
The first quarter of 2021 has been one of investor optimism as the vaccine rollout continues ahead of expectations and economic activity begins to accelerate in response. Within the Health IT industry, the already strong investment and M&A trends seen in 2020 have only accelerated. Over the course of the quarter, we observed $7 billion in private equity and venture capital investment across 158 companies. By comparison, Q1 of 2020 saw $3.2 billion and 127 investments. Health IT
Read More
Life Sciences Firm OrbiMed Raises $3.5B Across Private Investment Funds
What You Should Know: Life sciences investment firm OrbiMed announced $3.5 billion in commitments for its latest private investment funds, including $1.5 billion for OrbiMed Private Investments VIII, $800 million for OrbiMed Asia Partners IV, and $1.2 billion for OrbiMed Royalty & Credit Opportunities III. The three new funds include a broad range of medical institutions, university endowments, foundations, pension funds and sovereign wealth funds. - OrbiMed Private Investments
Read More
